Ingredient or product comparison
Comparison: Peptide Mechanisms for Dermal Remodeling
| Peptide/Compound | Primary Mechanism | Molecular Weight | Penetration Method | Collagen Upregulation | Clinical Evidence Level | Professional Assessment ||—|—|—|—|—|—|| GHK-Cu | TGF-β pathway activation, LOX cofactor, MMP inhibition | 340 Da | Passive diffus
This source-based comparison does not add ratings or recommend a winner.
- | Peptide/Compound | Primary Mechanism | Molecular Weight | Penetration Method | Collagen Upregulation | Clinical Evidence Level | Professional Assessment ||—|—|—|—|—|—|| GHK-Cu | TGF-β pathway activation, LOX cofactor, MMP inhibition | 340 Da | Passive diffusion (enhanced with penetrants) | 70–120% (COL1A1/COL3A1 mRNA) | Phase II trials, multiple RCTs | Most reliable balance of efficacy, stability, and penetration for sagging skin protocols || Matrixyl (palmitoyl pentapeptide-4) | TGF-β mimetic, indirect collagen signaling | 578 Da | Passive diffusion | 30–50% (varies by study) | Industry-funded trials, limited independent replication | Effective but less mechanistic clarity than GHK-Cu || Tretinoin (retinoic acid) | RAR nuclear receptor binding, increased turnover | 300 Da | Passive diffusion | 80–100% (indirect via RAR) | Extensive RCTs, FDA-approved | Gold standard but requires tolerance period and UV protection || Recombinant EGF | EGF receptor activation, cell proliferation | 6 k